Pleno Overview
- Year Founded
-
2017
- Status
-
Private
- Employees
-
37
- Latest Deal Type
-
Series B
- Latest Deal Amount
-
$25M
- Investors
-
5
Pleno General Information
Description
Developer of a multi-omic instrument designed for biological target detection for clinical testing and biomedical research. The company's platform provides monitoring of minimal residual disease and early multi-cancer screening, also detects a diverse collection of analytical targets that include deoxyribonucleic acid, ribonucleic acid, and protein biomarkers with unprecedented speed and precision, and leverages advanced microfluidics to automate all aspects of sample preparation and analysis, enabling healthcare providers to get access to diverse health monitoring technologies.
Contact Information
Website
www.plenoinc.comCorporate Office
- 6275 Nancy Ridge Drive
- Suite 100
- San Diego, CA 92121
- United States
Corporate Office
- 6275 Nancy Ridge Drive
- Suite 100
- San Diego, CA 92121
- United States
Pleno Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Later Stage VC (Series B) | 12-Dec-2024 | $25M | Completed | Generating Revenue | ||
| 3. Later Stage VC (Series A) | 25-May-2022 | Completed | Generating Revenue | |||
| 2. Accelerator/Incubator | 01-Feb-2022 | $8.55M | Completed | Generating Revenue | ||
| 1. Seed Round | $8.55M | $8.55M | Completed | Startup |
Pleno Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A-1 | ||||||||
| Series A | ||||||||
| Seed-1 | 8,017,517 | $0.000100 | $0.03 | $0.32 | $0.32 | 1x | $0.32 | 10.99% |
| Seed | 14,756,758 | $0.000100 | $0.03 | $0.4 | $0.4 | 1x | $0.4 | 20.22% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Pleno Comparisons
Industry
Financing
Details
Pleno Competitors (29)
One of Pleno’s 29 competitors is Genomic Expression, a Venture Capital-Backed company based in Beverly, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Genomic Expression | Venture Capital-Backed | Beverly, MA | ||||
| Flagship Biosciences | Formerly VC-backed | Broomfield, CO | ||||
| Vizgen | Venture Capital-Backed | Cambridge, MA | ||||
| Illumina | Formerly VC-backed | San Diego, CA | ||||
| Harvard Bioscience | Formerly PE-Backed | Holliston, MA |
Pleno Patents
Pleno Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026193009-A1 | Cancer recurrence monitoring | Pending | 10-Mar-2025 | ||
| WO-2026178412-A2 | Identification of methylated nucleic acids | Pending | 21-Feb-2025 | ||
| WO-2026178412-A3 | Identification of methylated nucleic acids | Pending | 21-Feb-2025 | ||
| WO-2026161646-A1 | Methods and compositions for increasing detection of structural variants | Pending | 24-Jan-2025 | ||
| WO-2026102120-A2 | Instrument registration for multi-well plate | Pending | 07-Nov-2024 | B01L3/5085 |
Pleno Signals
Pleno Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Alexandria Venture Investments | Venture Capital | Minority | ||
| Deerfield Management | Venture Capital | Minority | ||
| Foresite Capital | Growth/Expansion | Minority | ||
| Medical Excellence Capital | Venture Capital | Minority | ||
| EvoNexus | Accelerator/Incubator | Minority |
Pleno FAQs
-
When was Pleno founded?
Pleno was founded in 2017.
-
Where is Pleno headquartered?
Pleno is headquartered in San Diego, CA.
-
What is the size of Pleno?
Pleno has 37 total employees.
-
What industry is Pleno in?
Pleno’s primary industry is Discovery Tools (Healthcare).
-
Is Pleno a private or public company?
Pleno is a Private company.
-
What is Pleno’s current revenue?
The current revenue for Pleno is .
-
How much funding has Pleno raised over time?
Pleno has raised $73.6M.
-
Who are Pleno’s investors?
Alexandria Venture Investments, Deerfield Management, Foresite Capital, Medical Excellence Capital, and EvoNexus have invested in Pleno.
-
Who are Pleno’s competitors?
Genomic Expression, Flagship Biosciences, Vizgen, Illumina, and Harvard Bioscience are some of the 29 competitors of Pleno.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process